DYN

Dyne Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$18.84

Market Cap

$3.11B

Beta

1.40

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)-5.67%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-13.63%

Debt / Equity0.02

Interest Coverage-75.6x

No credit card required

Already have an account? Sign in to view the full analysis for DYN.